Abstract
Purpose
To determine the oncological outcomes of cervical esophageal squamous cell carcinoma (CESCC) treated with definitive chemoradiotherapy (CRT).
Methods
A systematic review and meta-analysis was performed according to the PRISMA guidelines.
Results
A total of 1222 patients (median age: 63.0 years, 95% CI 61.0–65.0) were included from 22 studies. The median follow-up time was 34.0 months (n = 1181, 95% CI 26.4–36.0). Estimated pooled OS rates (95% CI) at 1, 3, and 5 years were 77.9% (73.9–82.2), 48.4% (43.2–54.3), and 35.3% (29.7–41.9), respectively. The median OS (95% CI) was 33.4 months (25.8–42.2). Estimated pooled PFS rates (n = 595; 95% CI) at 1, 3, and 5 years were 64.1% (57.9–71.0), 38.0% (33.3–45.5), and 29.8% (23.9–37.1), respectively. The median PFS (95% CI) was 19.8 months (14.9–26.6).
Conclusions
Definitive CRT is a valuable first-line treatment for the management of CESCC. Further studies should focus on survival predictors able to define stage-based clinical guidelines.
Similar content being viewed by others
Data availability
Data and material are available on request.
References
Baujat B, Mahé C, Pignon J-P, Hill C (2002) A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Stat Med 21(18):2641–2652
Burmeister BH, Dickie G, Smithers BM, Hodge R, Morton K (2000) Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg 126(2):205–208
Cao C-N, Luo J-W, Gao L et al (2016) Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma: clinical outcomes and patterns of failure. Eur Arch Otorhinolaryngol 273(3):741–747
Castoro C, Scarpa M, Cagol M et al (2013) Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary? J Gastrointest Surg 17(8):1375–1381
Chen N-B, Qiu B, Zhang J et al (2020) Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in definitive chemoradiotherapy for cervical esophageal squamous cell carcinoma: comparison of survival outcomes and toxicities. Cancer Res Treat 52(1):31–40
Combescure C, Foucher Y, Jackson D (2014) Meta-analysis of single-arm survival studies: a distribution-free approach for estimating summary survival curves with random effects. Stat Med 33(15):2521–2537
Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiat Ther Oncol Group JAMA 281(17):1623–1627
Daiko H, Hayashi R, Saikawa M et al (2007) Surgical management of carcinoma of the cervical esophagus. J Surg Oncol 96(2):166–172
Efron B (1988) Logistic regression, survival analysis, and the Kaplan-Meier curve. J Am Stat Assoc 83(402):414–425
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Fenkell L, Kaminsky I, Breen S, Huang S, Van Prooijen M, Ringash J (2008) Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol 89(3):287–291
Fujita H, Sueyoshi S, Yamana H et al (2001) Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 25(4):424–431
Gkika E, Gauler T, Eberhardt W, Stahl M, Stuschke M, Pöttgen C (2014) Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Dis Esophagus 27(7):678–684
Greenstein AJ, Litle VR, Swanson SJ et al (2008) Racial disparities in esophageal cancer treatment and outcomes. Ann Surg Oncol 15(3):881–888
Herrmann E, Mertineit N, De Bari B et al (2017) Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study. Radiat Oncol 12(1):97
Hoeben A, Polak J, Van De Voorde L, Hoebers F, Grabsch HI, de Vos-Geelen J (2016) Cervical esophageal cancer: a gap in cancer knowledge. Ann Oncol 27(9):1664–1674
Hulshof MCCM et al (2021) Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study). J Clin Oncol 39(25):2816–2824
Inada M, Nishimura Y, Ishikawa K et al (2021) Outcome of chemoradiotherapy using intensity-modulated radiation therapy for cervical esophageal cancer: a single institute experience. Esophagus 18(3):638–644
Ito M, Kodaira T, Tachibana H et al (2017) Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy. Head Neck 39(12):2406–2415
Jackson D, White IR, Riley RD (2012) Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31(29):3805–3820
Jiang M, He X, Wu D, Han Y, Zhang H, Wang M (2015) Reconstruction techniques for hypopharyngeal and cervical esophageal carcinoma. J Thorac Dis 7(3):449–454
Kato H, Nakajima M (2013) Treatments for esophageal cancer: a review. Gen Thorac Cardiovasc Surg 61(6):330–335
Kim TH, Lee IJ, Kim J-H, Lee CG, Lee YC, Kim JW (2019) High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution study. Head Neck 41(1):146–153
Li H-X, Liu J, Cheng Y, Liu M-N, Fang W-T, Lv C-X (2018) Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study. Dis Esophagus 31(5):2816–2824
Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100
Markar SR, Karthikesalingam A, Penna M, Low DE (2014) Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis. Ann Surg Oncol 21(3):922–931
McDowell LJ, Huang SH, Xu W et al (2017) Effect of intensity modulated radiation therapy with concurrent chemotherapy on survival for patients with cervical esophageal carcinoma. Int J Radiat Oncol Biol Phys 98(1):186–195
McGrath S, Zhao X, Qin ZZ, Steele R, Benedetti A (2019) One-sample aggregate data meta-analysis of medians. Stat Med 38(6):969–984
Miyata H, Yamasaki M, Takahashi T et al (2013) Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus. World J Surg 37(3):551–557
Nakata Y, Hanai N, Nishikawa D et al (2017) Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma. Int J Clin Oncol 22(6):1034–1041
Napier KJ, Scheerer M, Misra S (2014) Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 6(5):112–120
National Comprehensive Cancer Network (2021) Esophageal and esophagogastric junction cancers (version 3.2021). https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf. Accessed 26 Jul 2021
National Institute for Health and Care Excellence (2012) Methods for the development of NICE public health guidance. National Institute for Health and Care Excellence (NICE), London
Okamoto H, Taniyama Y, Sakurai T et al (2018) Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer. Esophagus 15(4):281–285
Ott K, Lordick F, Molls M, Bartels H, Biemer E, Siewert JR (2009) Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg 96(3):258–266
Sakanaka K, Ishida Y, Fujii K et al (2018) Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma. Radiat Oncol 13(1):7
Schieman C, Wigle DA, Deschamps C et al (2013) Salvage resections for recurrent or persistent cancer of the proximal esophagus after chemoradiotherapy. Ann Thorac Surg 95(2):459–463
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30
Steyerberg EW, Earle CC, Neville BA, Weeks JC (2005) Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol 23(3):510–517
Sun F, Li X, Lei D et al (2014) Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction. Int J Clin Exp Med 7(9):2771–2778
Takebayashi K, Tsubosa Y, Matsuda S et al (2017) Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer. Dis Esophagus 30(2):1–5
Tepper J, Krasna MJ, Niedzwiecki D et al (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26(7):1086–1092
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16
Tong DKH, Law S, Kwong DLW, Wei WI, Ng RWM, Wong KH (2011) Current management of cervical esophageal cancer. World J Surg 35(3):600–607
Triboulet JP, Mariette C, Chevalier D, Amrouni H (2001) Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg 136(10):1164–1170
Uno T, Isobe K, Kawakami H et al (2007) Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus 20(1):12–18
Valmasoni M, Pierobon ES, Zanchettin G et al (2018) Cervical esophageal cancer treatment strategies: a cohort study appraising the debated role of surgery. Ann Surg Oncol 25(9):2747–2755
van Hagen P, Hulshof MCCM, van Lanschot JJB et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084
Wang H-W, Chu P-Y, Kuo K-T et al (2006) A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol 93(6):468–476
Wong R, Malthaner R (2006) Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 1:CD002092
Yamada K, Murakami M, Okamoto Y et al (2006) Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol 45(8):1120–1125
Yang H, Feng C, Cai B-N, Yang J, Liu H-X, Ma L (2017) Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma. Dis Esophagus 30(2):1–8
Zenda S, Kojima T, Kato K et al (2016) Multicenter phase 2 study of cisplatin and 5-fluorouracil with concurrent radiation therapy as an organ preservation approach in patients with squamous cell carcinoma of the cervical esophagus. Int J Radiat Oncol Biol Phys 96(5):976–984
Zhang Y (2013) Epidemiology of esophageal cancer. World J Gastroenterol 19(34):5598–5606
Zhang P, Xi M, Zhao L et al (2015) Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol 116(2):257–261
Zhao L, Zhou Y, Mu Y et al (2017) Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer. Oncotarget 8(13):21852–21860
Zhao D, Zheng B, Xiao S et al (2020) Mapping of regional failures after definitive radiotherapy in patients with locally advanced cervical esophageal carcinoma. Cancer Manag Res 12:5293–5299
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethics approval
Not required.
Consent to participate
Not applicable.
Consent to publish
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Virgilio, A., Costantino, A., Festa, B.M. et al. Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis. J Cancer Res Clin Oncol 149, 1029–1041 (2023). https://doi.org/10.1007/s00432-022-03965-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-022-03965-8